Ho Maykin is a director of Neumora Therapeutics Inc.
Person profile
Roles
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
BIOMARIN PHARMACEUTICAL INC
23 May 24
4
Neumora Therapeutics, Inc.
18 Sep 23
3
Neumora Therapeutics, Inc.
14 Sep 23
4
AGIOS PHARMACEUTICALS, INC.
23 Jun 23
4
AGIOS PHARMACEUTICALS, INC.
15 Jun 23
4
FIBROGEN INC
9 Jun 23
144
FIBROGEN INC
8 Jun 23
4
BIOMARIN PHARMACEUTICAL INC
24 May 23
4
AGIOS PHARMACEUTICALS, INC.
23 Jun 22
4
FIBROGEN INC
21 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 May 24 | BMRN Biomarin Pharmaceutical Inc. - Registered Shares | Common Stock | Grant | Acquire A | No | No | 0 | 4,720 | 0.00 | 21,360 |
14 Sep 23 | NMRA Neumora Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 17 | 27,802 | 472.63 k | 27,802 |
21 Jun 23 | AGIO Agios Pharmaceuticals | Common stock | Option exercise | Acquire M | No | No | 0 | 4,975 | 0.00 | 11,524 |
21 Jun 23 | AGIO Agios Pharmaceuticals | RSU Common stock | Option exercise | Dispose M | No | No | 0 | 4,975 | 0.00 | 0 |
13 Jun 23 | AGIO Agios Pharmaceuticals | Stock options Common stock | Grant | Acquire A | No | No | 26.56 | 18,958 | 503.52 k | 18,958 |
13 Jun 23 | AGIO Agios Pharmaceuticals | RSU Common stock | Grant | Acquire A | No | No | 0 | 3,388 | 0.00 | 3,388 |